Deep Brain Stimulation Devices Market Product: Single-channel vs. Dual-channel The deep brain stimulation devices market can be segmented based on the product type, specifically single-channel and dual-channel devices. Single-channel devices are designed to deliver electrical stimulation to targeted areas of the brain, while dual-channel devices offer the ability to stimulate multiple areas simultaneously. In recent years, there has been a growing demand for dual-channel devices due to their enhanced flexibility and customization options for patients with complex neurological disorders. Application: Parkinson’s Disease vs. Epilepsy Another key segment in the deep brain stimulation devices market is based on the application, with a focus on Parkinson's disease and epilepsy. Deep brain stimulation has been proven to be an effective treatment for symptoms of Parkinson's disease, such as tremors and rigidity, by delivering electrical impulses to specific areas of the brain. Similarly, deep brain stimulation has shown promising results in managing drug-resistant epilepsy in patients who have not responded to traditional treatments. The increasing prevalence of these neurological disorders is expected to drive the demand for deep brain stimulation devices in the coming years. End-use: Hospitals vs. ASCs The end-use segment of the deep brain stimulation devices market includes hospitals and ambulatory surgical centers (ASCs). Hospitals are the primary settings where deep brain stimulation procedures are performed, given the need for specialized equipment and trained healthcare professionals to carry out the implantation and programming of these devices. However, ASCs are also becoming increasingly popular for deep brain stimulation surgeries, as they offer a more cost-effective and convenient option for patients requiring outpatient procedures. With the growing trend towards minimally invasive surgeries and outpatient care, ASCs are expected to play a significant role in the adoption of deep brain stimulation devices.